FDA Inspection
Optum Compounding Services, LLCOptum Compounding Services, LLC – FDA Inspection, Apr 20, 2018
Record Details
This FDA Inspection record concerns Optum Compounding Services, LLC, with an inspection on April 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 00bab727-2e9f-430c-83fb-315470a6441b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048973
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.142(b)Storage under appropriate conditions
- FDCA 503B(a)(10)Drug product label, outsourcer facility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Optum Compounding Services, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 13, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Optum Compounding Services, LLC
- FDA Inspection 1148980 - 2021-08-13
- FDA Inspection 1013242 - 2017-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.